InvestorsHub Logo
Followers 11
Posts 690
Boards Moderated 0
Alias Born 11/24/2015

Re: RedShoulder post# 431201

Monday, 09/18/2023 10:56:42 AM

Monday, September 18, 2023 10:56:42 AM

Post# of 458511
"Alzheimer Agent Blarcamesine Shows Significant Reduction of Amyloid-ß Biomarkers in Phase 2b/3 Trial
Sep 15, 2023"

One might assume this data is highly interesting to a potential big pharma partner, especially one that hasn't sunk millions in the brute force amyloid plaque removal dogma. Thanks for sharing.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News